๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pilot study of multiple chemotherapy resistance modulators plus epirubicin in the treatment of resistant malignancies

โœ Scribed by David J. Stewart; M. Christine Cripps; Rakesh Goel; Simone Dahrouge; Jonathan Yau; Eva Tomiak; Susan Huan; Kathy Soltys; Ann Prosser; Ross A. Davies; M. Christine Cripps

Publisher
Springer
Year
1997
Tongue
English
Weight
148 KB
Volume
41
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Combination chemotherapy plus BCG in the
Combination chemotherapy plus BCG in the treatment of disseminated malignant melanoma: A southwest oncology group study
โœ Costanzi, John J. ;Al-Sarraf, Muhyi ;Groppe, Carl ;Bottomley, Richard ;Fabian, C ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 466 KB

## Abstract The Southwest Oncology Group performed a randomized study comparing combination chemotherapy alone versus combination chemotherapy plus BCG versus DTIC plus BCG in the treatment of disseminated malignant melanoma. A 31% response rate was noted with combination chemotherapy alone, a 27%

Phase II study of gemcitabine plus vinor
Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma
โœ Chuan-Cheng Wang; Jang-Yang Chang; Tsang-Wu Liu; Chin-Yu Lin; Yu-Chieh Yu; Ruey- ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 90 KB

Background. A phase II study was conducted to evaluate the safety and efficacy of a gemcitabine plus vinorelbine combination (GV) for patients with cisplatin-resistant nasopharyngeal carcinoma (NPC). Methods. Thirty-nine eligible patients received vinorelbine, 20 mg/m 2 , followed by gemcitabine, 1